N-acetylcysteine reverses cardiac myocyte dysfunction in HIV-Tat proteinopathy

Journal of Applied Physiology

Volumn 113, Issue 1, 2012, Pages 105-113

  Chen, Fangping ^a   Lewis, William ^c   Hollander, John M ^a   Baseler, Walter ^a   Finkel, Mitchell S ^a,b  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LA Johnson Veterans Affairs Medical Center   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal model; Cardiomyopathy; Heart failure; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; ANTIVIRUS AGENT; CALCIUM; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 1; HYDROGEN PEROXIDE; TRANSACTIVATOR PROTEIN;

ANIMAL; ARTICLE; CARDIOMYOPATHY; DRUG EFFECT; FEMALE; HEART CONTRACTION; HEART MUSCLE CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; METABOLISM; MOUSE; OXIDATIVE STRESS; PHYSIOLOGY; TRANSGENIC MOUSE; VIROLOGY;

ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIVIRAL AGENTS; CALCIUM; CARDIOMYOPATHIES; CATALASE; FEMALE; GENE PRODUCTS, TAT; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HIV INFECTIONS; HYDROGEN PEROXIDE; MALE; MICE; MICE, TRANSGENIC; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; OXIDATIVE STRESS;

EID: 84863320313     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00068.2012     Document Type: Article

References (56)

1. Akki A, Zhang M, Murdoch C, Brewer A, Shah AM. NADPH oxidase signaling and cardiac myocyte function. J Mol Cell Cardiol 47:15-22, 2009.
2. Atkuri KR, Mantovani JJ, Herzenberg LA. N-acetylcysteine-a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol 7:355-359, 2007. (Pubitemid 47289259)
3. + channels: a potential mechanism of HIV infection induced LQTs. J Mol Cell Cardiol 51:876-880, 2011.
4. Barbaro G. Heart and HAART: two sides of the coin for HIV-associated cardiology issues. World J Cardiol 2:53-57, 2010.
5. Borges-Santos MD, Moreto F, Pereira PC, Ming-Yu Y, Burini RC. Plasma glutathione of HIV (+) patients responded positively and differently to dietary supplementation with cysteine or glutamine. Nutrition 2012 Jan 18 [Epub ahead of print].
6. Chaves AA, Mihm MJ, Schanbacher BL, Basuray A, Liu C, Ayers LW, Bauer JA. Cardiomyopathy in a murine model of AIDS: evidence of reactive nitrogen species and corroboration in human HIV/AIDS cardiac tissues. Cardiovasc Res 60:108-118, 2003. (Pubitemid 38373481)
7. Chen F, Kan H, Hobbs G, Finkel MS. p38 MAP kinase inhibitor reverses stress-induced myocardial dysfunction in vivo. J Appl Physiol 106:1132-1141, 2009.
8. Choi J, Liu RM, Kundu RK, Sangiorgi F, Wu W, Maxson R, Forman HJ. Molecular mechanism of decreased glutathione content in human immunodeficiency virus type 1 Tat-transgenic mice. J Biol Chem 275:3693-3698, 2000. (Pubitemid 30083082)
9. Choy KH, Dean O, Berk M, Bush AI, van den Buuse M. Effects of N-acetyl-cysteine treatment on glutathione depletion and a short-term spatial memory deficit in 2-cyclohexene-1-one-treated rats. Eur J Pharmacol 649:224-228, 2010.
10. De Rosa SC, Zaretsky MD, Dubs JG, Roederer M, Anderson M, Green A, Mitra D, Watanabe N, Nakamura H, Tjioe I, Deresinski SC, Moore WA, Ela SW, Parks D, Herzenberg LA. N-acetylcysteine replenishes glutathione in HIV infection. Eur J Clin Invest 30:915-929, 2000.
11. Fang Q, Kan H, Lewis W, Chen F, Sharma P, Finkel MS. Dilated cardiomyopathy in transgenic mice expressing HIV Tat. Cardiovasc Toxicol 9:39-45, 2009.
12. Ferrari R, Guardigli G, Mele D, Percoco GF, Ceconi C, Curello S. Oxidative stress during myocardial ischaemia and heart failure. Curr PharmDes 10:1699-1711, 2004. (Pubitemid 38559780)
13. Fiala M, Popik W, Qiao JH, Lossinsky AS, Alce T, Tran K, Yang W, Roos KP, Arthos J. HIV-1 induces cardiomyopathy by cardiomyocyte invasion and gp120, Tat, and cytokine apoptotic signaling. Cardiovasc Toxicol 4:97-107, 2004. (Pubitemid 39310744)
14. Finkel MS, Marks ES, Patterson RE, Speir EH, Steadman K, Keiser HR. Increased cardiac calcium channels in hamster cardiomyopathy. Am J Cardiol 57:1205-1206, 1986. (Pubitemid 16020934)
15. Fisher SD, Easley KA, Orav EJ, Colan SD, Kaplan S, Starc TJ, Bricker JT, Lai WW, Moodie DS, Sopko G, Lipshultz SE; Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group. Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV Multicenter Study. Am Heart J 150:439-447, 2005. (Pubitemid 41317610)
16. Goldhaber JI, Qayyum MS. Oxygen free radicals and excitation-contraction coupling. Antioxid Redox Signal 2:55-64, 2000. (Pubitemid 30202454)
17. Groenendyk J, Sreenivasaiah PK, Kim DH, Agellon LB, Michalak M. Biology of endoplasmic reticulum stress in the heart. Circ Res 107:1185-1197, 2010.
18. Han YH, Yang YM, Kim SZ, Park WH. Attenuation of MG132-induced HeLa cell death by N-acetyl cysteine via reducing reactive oxygen species and preventing glutathione depletion. Anticancer Res 30:2107-2112, 2010.
19. Herskowitz A, Wu TC, Willoughby SB, Vlahov D, Ansari AA, Beschorner WE, Baughman KL. Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. J Am Coll Cardiol 24:1025-1032, 1994. (Pubitemid 24306414)
20. Herzenberg LA, De Rosa SC, Dubs JG, Roederer M, Anderson MT, Ela SW, Deresinski SC. Glutathione deficiency is associated with impaired survival in HIV disease. Proc Natl Acad Sci USA 94:1967-1972, 1997. (Pubitemid 27113945)
21. Ho WZ, Douglas SD. Glutathione and N-acetylcysteine suppression of human immunodeficiency virus replication in human monocyte/macrophages in vitro. AIDS Res Hum Retroviruses 8:1249-1253, 1992.
22. Holdiness MR. Clinical pharmacokinetics of N-acetylcysteine. Clin Pharmacokinet 20:123-134, 1991.
23. Hollander J, Gore M, Fiebig R, Mazzeo R, Ohishi S, Ohno H, Ji LL. Spaceflight downregulates antioxidant defense systems in rat liver. Free Radic Biol Med 24:385-390, 1998. (Pubitemid 28008818)
24. Kan H, Xie Z, Finkel MS. iPLA2 inhibitor blocks negative inotropic effect of HIV gp120 on cardiac myocytes. J Mol Cell Cardiol 40:131-137, 2006. (Pubitemid 43012124)
25. Kan H, Xie Z, Finkel MS. p38 MAP kinase-mediated negative inotropic effect of HIV gp120 on cardiac myocytes. Am J Physiol Cell Physiol 286:C1-C7, 2004. (Pubitemid 38055807)
26. Kerksick C, Willoughby D. The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress. J Int Soc Sports Nutr 2:38-44, 2005.
27. Khunnawat C, Mukerji S, Havlichek D, Touma R, Abela GS. Cardiovascular manifestations in human immunodeficiency virus-infected patients. Am J Cardiol 102:635-642, 2008.
28. Koczor C, Kohler J, Lewis W. Transgenic mouse models of mitochondrial toxicity associated with HIV/AIDS and antiretrovirals. Methods 51:399-404, 2010.
29. Kristoffersen US, Lebech AM, Gerstoft J, Hesse B, Petersen CL, Gutte H, Kjaer A. Right and left cardiac function in HIV-infected patients investigated using radionuclide ventriculography and brain natriuretic peptide: a 5-year follow-up study. HIV Med 9:180-186, 2008. (Pubitemid 351279574)
30. Kuroda J, Ago T, Matsushima S, Zhai P, Schneider MD, Sadoshima J. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc Natl Acad Sci USA 107:15565-15570, 2010.
31. Kushnir A, Marks AR. The ryanodine receptor in cardiac physiology and disease. Adv Pharmacol 59:1-30, 2010.
32. Leeuwenburgh C, Hollander J, Leichtweis S, Griffiths M, Gore M, Ji LL. Adaptations of glutathione antioxidant system to endurance training are tissue and muscle fiber specific. Am J Physiol Regul Integr Comp Physiol 272:R363-R369, 1997.
33. Lewis W. Mitochondrial DNA replication, nucleoside reverse-transcriptase inhibitors, and AIDS cardiomyopathy. Prog Cardiovasc Dis 45:305-318, 2003. (Pubitemid 36293026)
34. Lewis W, Day BJ, Copeland WC. Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective. Nat Rev Drug Discov 2:812-822, 2003. (Pubitemid 37361813)
35. Lledías F, Rangel P, Hansberg W. Oxidation of catalase by singlet oxygen. J Biol Chem 273:10630-10637, 1998. (Pubitemid 28227676)
36. Meenakshisundaram R, Sweni S, Thirumalaikolundusubramanian P. Cardiac isoform of alpha 2 macroglobulin: a marker of cardiac involvement in pediatric HIV and AIDS. Pediatr Cardiol 31:203-207, 2010.
37. Nakamura H, Masutani H, Yodoi J. Redox imbalance and its control in HIV infection. Antioxid Redox Signal 4:455-464, 2002. (Pubitemid 34753384)
38. Nigro V, Okazaki Y, Belsito A, Piluso G, Matsuda Y, Politano L, Nigro G, Ventura C, Abbondanza C, Molinari AM, Acampora D, Nishimura M, Hayashizaki Y, Puca GA. Identification of the Syrian hamster cardiomyopathy gene. Hum Mol Genet 6:601-607, 1997. (Pubitemid 27142112)
39. Norman JP, Perry SW, Reynolds HM, Kiebala M, De Mesy Bentley KL, Trejo M, Volsky DJ, Maggirwar SB, Dewhurst S, Masliah E, Gelbard HA. HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization. PLos One 3:e3731, 2008.
40. max. J Neurosci 30:14153-14164, 2010.
41. Price TO, Ercal N, Nakaoke R, Banks WA. HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. Brain Res 1045:57-63, 2005. (Pubitemid 40725220)
42. 2+ signaling in the heart: the role of ryanodine receptor sensitivity. J Gen Physiol 136:135-142, 2010.
43. Raidel SM, Haase C, Jansen NR, Russ RB, Sutliff RL, Velsor LW, Day BJ, Hoit BD, Samarel AM, Lewis W. Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage. Am J Physiol Heart Circ Physiol 282:H1672-H1678, 2002. (Pubitemid 34654834)
44. Richard MJ, Guiraud P, Didier C, Seve M, Flores SC, Favier A. Human immunodeficiency virus type 1 Tat protein impairs selenoglutathione peroxidase expression and activity by a mechanism independent of cellular selenium uptake: consequences on cellular resistance to UV-A radiation. Arch Biochem Biophys 386:213-220, 2001. (Pubitemid 32989310)
45. Roederer M, Ela SW, Staal FJ, Herzenberg LA. N-acetylcysteine: a new approach to anti-HIV therapy. AIDS Res Hum Retroviruses 8:209-217, 1992.
46. Romani B, Engelbrecht S, Glashoff RH. Functions of Tat: the versatile protein of human immunodeficiency virus type 1. J Gen Virol 91:1-12, 2010.
47. Sakamoto A, Ono K, Abe M, Jasmin G, Eki T, Murakami Y, Masaki T, Toyo-oka T, Hanaoka F. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. Proc Natl Acad Sci USA 94:13873-13878, 1997. (Pubitemid 28009677)
48. 2+ release from the sarcoplasmic reticulum of skinned rabbit psoas fibres. J Physiol 454:389-420, 1992.
49. Shannon RP. SIV cardiomyopathy in non-human primates. Trends Cardiovasc Med 11:242-246, 2001. (Pubitemid 32982915)
50. 2+ sensitivity and excitationcontraction coupling in muscular dystrophy and heart failure: similar and yet different. Am J Physiol Heart Circ Physiol 297:H1965-H1966, 2009.
51. Visalli V, Muscoli C, Sacco I, Sculco F, Palma E, Costa N, Colica C, Rotiroti D, Mollace V. N-acetylcysteine prevents HIV gp 120-related damage of human cultured astrocytes: correlation with glutamine synthase dysfunction. BMC Neurosci 8:106, 2007.
52. Wang K, Tu Y, Rappel WJ, Levine H. Excitation-contraction coupling gain and cooperativity of the cardiac ryanodine receptor: a modeling approach. Biophys J 89:3017-3025, 2005. (Pubitemid 41636058)
53. Whitehead NP, Pham C, Gervasio OL, Allen DG. N-acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice. J Physiol 586:2003-2014, 2008. (Pubitemid 351997524)
54. Williams IA, Allen DG. The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice. Am J Physiol Heart Circ Physiol 293:H1969-H1977, 2007. (Pubitemid 47367249)
55. 2 mediates endoplasmic reticulum signaling through local Ras activation. Mol Cell Biol 30:3553-3568, 2010.
56. Yuan Y, Kan H, Fang Q, Chen F, Finkel MS. CXCR4 receptor antagonist blocks cardiac myocyte p38 MAP kinase phosphorylation by HIV gp120. Cardiovasc Toxicol 8:173-180, 2008.